Los Angeles Capital Management’s Guardant Health GH Stock Holding History

Los Angeles Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$537K	Sell	3,578 -7,188	-67%	-$782K	﹤0.01%	896
2026 Q1	$994K	Buy	10,766 +1,636	+18%	+$164K	﹤0.01%	684
2025 Q4	$844K	Buy	+9,130	New	+$817K	﹤0.01%	700
2024 Q1	–	Sell	-14,793	Closed	-$400K	–	1163
2023 Q4	$400K	Buy	14,793 +3,218	+28%	+$84.4K	﹤0.01%	936
2023 Q3	$343K	Sell	11,575 -4,285	-27%	-$151K	﹤0.01%	925
2023 Q2	$568K	Buy	+15,860	New	+$455K	﹤0.01%	813
2022 Q1	–	Sell	-2,178	Closed	-$218K	–	1440
2021 Q4	$218K	Sell	2,178 -110	-5%	-$11.4K	﹤0.01%	1331
2021 Q3	$286K	Sell	2,288 -1,075	-32%	-$128K	﹤0.01%	1326
2021 Q2	$418K	Hold	3,363	–	–	﹤0.01%	1257
2021 Q1	$513K	Sell	3,363 -980	-23%	-$148K	﹤0.01%	1209
2020 Q4	$560K	Buy	4,343 +1,608	+59%	+$185K	﹤0.01%	1167
2020 Q3	$306K	Buy	2,735 +180	+7%	+$16.5K	﹤0.01%	1262
2020 Q2	$207K	Buy	+2,555	New	+$206K	﹤0.01%	1394
2019 Q4	–	Sell	-3,950	Closed	-$252K	–	1296
2019 Q3	$252K	Buy	+3,950	New	+$348K	﹤0.01%	1162

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Los Angeles Capital Management's GH Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Guardant Health (GH) stake by 67% in Q2 2026, selling an estimated $782K and leaving 3,578 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Los Angeles Capital Management first reported a position in GH in Q3 2019 and has held it in 14 quarters since. The position peaked at $994K in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Los Angeles Capital Management held 3,578 shares of Guardant Health worth $537K as of Q2 2026.
Los Angeles Capital Management sold 7,188 Guardant Health shares in Q2 2026, an estimated $782K.
Guardant Health made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #896 holding.
Los Angeles Capital Management first reported a position in Guardant Health in Q3 2019 and has held it in 14 quarters since.
Los Angeles Capital Management's Guardant Health position peaked at $994K in Q1 2026.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.